Coronavirus vaccine stocks were the biggest investment theme of 2020. Since, two biotech companies -- Moderna (NASDAQ: MRNA) and BioNTech -- actually have commercialized their vaccines. Let's take a look at where they're at with vaccine programs -- and whether they're on track to beat the market in the second half.
Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting